Jens Würthner

Jens has 20+ years of clinical development experience from research institutions as well as big pharma and biotech companies including Novartis, GlaxoSmithKline, AstraZeneca, and most recently ADC Therapeutics. Jens joined Scenic in 2022 as Chief Medical Officer.